{Reference Type}: Journal Article
{Title}: Serum PYCARD may become a new diagnostic marker for rheumatoid arthritis patients.
{Author}: Geng XL;Jiang YS;Zhao CN;Zhang ZZ;Liu YL;Ding PJ;
{Journal}: Eur J Med Res
{Volume}: 29
{Issue}: 1
{Year}: 2024 Apr 4
{Factor}: 4.981
{DOI}: 10.1186/s40001-024-01813-8
{Abstract}: BACKGROUND: The objective of this investigation is to analyze the levels and clinical relevance of serum PYCARD (Pyrin and CARD domain-containing protein, commonly known as ASC-apoptosis-associated speck-like protein containing a caspase activation and recruitment domain), interleukin-38 (IL-38), and interleukin-6 (IL-6) in individuals afflicted with rheumatoid arthritis (RA).
METHODS: Our study comprised 88 individuals diagnosed with RA who sought medical attention at the Affiliated Hospital of Chengde Medical University during the period spanning November 2021 to June 2023, constituting the test group. Additionally, a control group of 88 individuals who underwent health assessments at the same hospital during the aforementioned timeframe was included for comparative purposes. The study involved the assessment of IL-38, IL-6, PYCARD, anti-cyclic citrullinated peptide antibody (anti-CCP), and erythrocyte sedimentation rate (ESR) levels in both groups. The research aimed to explore the correlations and diagnostic efficacy of these markers, employing pertinent statistical analyses for comprehensive evaluation.
RESULTS: The test group had higher expression levels of PYCARD, IL-6, and IL-38 than the control group (Pā<ā0.05). Based on the correlation analysis, there was a strong relationship between PYCARD and IL-38 (Pā<ā0.01). The receiver operating characteristic (ROC) curve analysis revealed area under the curve (AUC) values of 0.97, 0.96, and 0.96 when using combinations of PYCARD and anti-CCP, IL-38 and anti-CCP, and IL-6 and anti-CCP for predicting RA, respectively. Importantly, all three of these pairs demonstrated superior AUC values compared to PYCARD, IL-38, IL-6, ESR, or anti-CCP used as standalone diagnostic indicators.
CONCLUSIONS: PYCARD, IL-6, and IL-38 exhibit promising potential as novel diagnostic markers and may constitute valuable tools for supporting the diagnosis of RA.